Novavax
NVAX
#5751
Rank
โ‚น100.94 B
Marketcap
โ‚น621.18
Share price
0.73%
Change (1 day)
-11.62%
Change (1 year)

Novavax (NVAX) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น22.57 Billion

According to Novavax's latest financial reports the company's total debt is โ‚น22.57 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novavax - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น19.76 B3.65%
2023-12-31โ‚น19.07 B-58.08%
2022-12-31โ‚น45.49 B34.63%
2021-12-31โ‚น33.79 B-1.27%
2020-12-31โ‚น34.22 B49.11%
2019-12-31โ‚น22.95 B2.84%
2018-12-31โ‚น22.31 B10%
2017-12-31โ‚น20.28 B-5.62%
2016-12-31โ‚น21.49 B81793.25%
2015-12-31โ‚น26.24 M-58.5%
2014-12-31โ‚น63.25 M-45.57%
2013-12-31โ‚น0.11 B76.13%
2012-12-31โ‚น65.97 M289.75%
2011-12-31โ‚น16.92 M-5.56%
2010-12-31โ‚น17.92 M-20.52%
2009-12-31โ‚น22.55 M-97.95%
2008-12-31โ‚น1.10 B23.33%
2007-12-31โ‚น0.89 B-13.07%
2006-12-31โ‚น1.02 B-25.25%
2005-12-31โ‚น1.37 B-14.64%
2004-12-31โ‚น1.60 B-16.16%
2003-12-31โ‚น1.91 B-3.31%
2002-12-31โ‚น1.98 B19.84%
2001-12-31โ‚น1.65 B77.5%
2000-12-31โ‚น0.93 B21371.69%
1999-12-31โ‚น4.34 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Agenus
AGEN
โ‚น4.11 B-81.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น112.38 B 397.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น59.61 B 164.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น58.02 B 157.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น2.933 T 12,893.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚น5.469 T 24,128.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น2.878 T 12,650.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
โ‚น0.13 B-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น2.145 T 9,401.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚น0.23 B-98.96%๐Ÿ‡บ๐Ÿ‡ธ USA